Lazard Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
TCM
CIEC
GLF
EPM
QOP
Lazard Asset Management's BLUE Position: Q1 2025 in Review
Lazard Asset Management sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 17 shares.
Lazard Asset Management first reported a position in BLUE in Q4 2014 and held it in 24 quarters. The position peaked at $437K in Q4 2014. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.
- Lazard Asset Management reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
- Lazard Asset Management sold 17 bluebird bio shares in Q1 2025.
- Lazard Asset Management first reported a position in bluebird bio in Q4 2014 and held it in 24 quarters.
- Lazard Asset Management's bluebird bio position peaked at $437K in Q4 2014.
- 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.
Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.